These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36843560)

  • 1. When dysbiosis meets dystrophy: an unwanted gut-muscle connection.
    Jayaraman A; Pettersson S
    EMBO Mol Med; 2023 Mar; 15(3):e17324. PubMed ID: 36843560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy.
    Kalkan H; Pagano E; Paris D; Panza E; Cuozzo M; Moriello C; Piscitelli F; Abolghasemi A; Gazzerro E; Silvestri C; Capasso R; Motta A; Russo R; Di Marzo V; Iannotti FA
    EMBO Mol Med; 2023 Mar; 15(3):e16225. PubMed ID: 36594243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice.
    Farini A; Tripodi L; Villa C; Strati F; Facoetti A; Baselli G; Troisi J; Landolfi A; Lonati C; Molinaro D; Wintzinger M; Gatti S; Cassani B; Caprioli F; Facciotti F; Quattrocelli M; Torrente Y
    EMBO Mol Med; 2023 Mar; 15(3):e16244. PubMed ID: 36533294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Duchenne muscular dystrophy gene and cancer.
    Jones L; Naidoo M; Machado LR; Anthony K
    Cell Oncol (Dordr); 2021 Feb; 44(1):19-32. PubMed ID: 33188621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
    Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
    EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of muscular dystrophy model rats with a CRISPR/Cas system.
    Nakamura K; Fujii W; Tsuboi M; Tanihata J; Teramoto N; Takeuchi S; Naito K; Yamanouchi K; Nishihara M
    Sci Rep; 2014 Jul; 4():5635. PubMed ID: 25005781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum profiling identifies novel muscle miRNA and cardiomyopathy-related miRNA biomarkers in Golden Retriever muscular dystrophy dogs and Duchenne muscular dystrophy patients.
    Jeanson-Leh L; Lameth J; Krimi S; Buisset J; Amor F; Le Guiner C; Barthélémy I; Servais L; Blot S; Voit T; Israeli D
    Am J Pathol; 2014 Nov; 184(11):2885-98. PubMed ID: 25194663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting fibrosis in Duchenne muscular dystrophy.
    Zhou L; Lu H
    J Neuropathol Exp Neurol; 2010 Aug; 69(8):771-6. PubMed ID: 20613637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy.
    Chesshyre M; Ridout D; Hashimoto Y; Ookubo Y; Torelli S; Maresh K; Ricotti V; Abbott L; Gupta VA; Main M; Ferrari G; Kowala A; Lin YY; Tedesco FS; Scoto M; Baranello G; Manzur A; Aoki Y; Muntoni F
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1360-1372. PubMed ID: 35083887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of qPCR Reference Genes Suitable for Normalizing Gene Expression in a Canine Model of Duchenne Muscular Dystrophy.
    Hildyard JCW; Taylor-Brown F; Massey C; Wells DJ; Piercy RJ
    J Neuromuscul Dis; 2018; 5(2):177-191. PubMed ID: 29614692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microRNA miR-133b functions to slow Duchenne muscular dystrophy pathogenesis.
    Taetzsch T; Shapiro D; Eldosougi R; Myers T; Settlage RE; Valdez G
    J Physiol; 2021 Jan; 599(1):171-192. PubMed ID: 32991751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empowering Muscle Stem Cells for the Treatment of Duchenne Muscular Dystrophy.
    Filippelli RL; Chang NC
    Cells Tissues Organs; 2022; 211(6):641-654. PubMed ID: 33910206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD133+ cells derived from skeletal muscles of Duchenne muscular dystrophy patients have a compromised myogenic and muscle regenerative capability.
    Meng J; Muntoni F; Morgan J
    Stem Cell Res; 2018 Jul; 30():43-52. PubMed ID: 29783100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GRMD cardiac and skeletal muscle metabolism gene profiles are distinct.
    Markham LW; Brinkmeyer-Langford CL; Soslow JH; Gupte M; Sawyer DB; Kornegay JN; Galindo CL
    BMC Med Genomics; 2017 Apr; 10(1):21. PubMed ID: 28390424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced dimethylarginine degradation improves coronary flow reserve and exercise tolerance in Duchenne muscular dystrophy carrier mice.
    Garbincius JF; Merz LE; Cuttitta AJ; Bayne KV; Schrade S; Armstead EA; Converso-Baran KL; Whitesall SE; D'Alecy LG; Michele DE
    Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H582-H603. PubMed ID: 32762558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy.
    Ponnusamy S; Sullivan RD; You D; Zafar N; He Yang C; Thiyagarajan T; Johnson DL; Barrett ML; Koehler NJ; Star M; Stephenson EJ; Bridges D; Cormier SA; Pfeffer LM; Narayanan R
    Hum Mol Genet; 2017 Jul; 26(13):2526-2540. PubMed ID: 28453658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
    Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
    J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free intramuscular Mg
    Reyngoudt H; Lopez Kolkovsky AL; Carlier PG
    NMR Biomed; 2019 Sep; 32(9):e4115. PubMed ID: 31184793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.